How Longevity Apps Are Tracking Biological Age With Wearable Biomarkers

The longevity industry has traditionally relied on clinical tests to measure biological age — blood draws for epigenetic clocks, lab panels for metabolic markers, imaging for organ-specific aging. These tests are accurate but infrequent, expensive, and inaccessible to most consumers.

Wearable devices are changing this equation. Research published in Nature Communications and npj Digital Medicine now demonstrates that consumer wearables — the Apple Watch, Oura Ring, and similar devices people already wear — can estimate biological age from passively collected data. Not with the precision of a blood-based epigenetic clock, but continuously, cheaply, and at population scale.

This convergence of longevity science and consumer wearable data is creating a new product category. The biohacking and longevity market is valued at $38–56 billion and growing at 19–25% annually [1][2]. The products winning this market will be the ones that translate complex aging science into data-driven experiences users engage with daily.

How biological age works

Chronological age counts years since birth. Biological age estimates how old your body actually is — reflecting the accumulated effects of genetics, lifestyle, disease, stress, sleep, nutrition, and environment.

The distinction matters because biological age is a stronger predictor of health outcomes and mortality than chronological age. Two 50-year-olds can be biologically 42 and 58 respectively — with dramatically different disease risk, functional capacity, and life expectancy.

Traditional measurement: epigenetic clocks

The gold standard for biological age measurement is the epigenetic clock — an algorithm that reads DNA methylation patterns from a blood sample to estimate biological age. Developed by researchers like Steve Horvath and Morgan Levine, epigenetic clocks have been validated across large populations and predict mortality, disease onset, and functional decline.

Limitations: they require a blood draw, cost $200–500+ per test, take days to process, and provide a single snapshot. You can’t take one every morning.

The wearable alternative: continuous aging signals

Consumer wearables can’t read DNA methylation. But they continuously measure physiological signals that correlate with biological aging processes — heart rate dynamics, sleep architecture, circadian rhythms, activity patterns, and cardiovascular function. Research now shows these signals can be combined into wearable-based aging clocks that predict age-related health outcomes.

The trade-off: lower precision per measurement, but dramatically higher frequency, accessibility, and scale.

The research: wearable aging clocks

PpgAge (Nature Communications, 2025)

PpgAge is an aging clock built from photoplethysmography (PPG) data — the optical heart rate signal that every modern smartwatch and ring captures [3].

The study analyzed data from 213,593 participants in the Apple Heart & Movement Study, encompassing over 149 million participant-days. Key findings:

• Participants with an elevated “PpgAge gap” (predicted age exceeding chronological age) showed significantly higher rates of heart disease, heart failure, and diabetes [3]
• PpgAge predicted incident cardiovascular events and new diagnoses even after controlling for established risk factors
• The clock detected sharp biological age increases during pregnancy and concurrent with cardiac events — demonstrating sensitivity to acute physiological stress
• PpgAge associated with behavioral factors including smoking, exercise patterns, and sleep quality [3]

The breakthrough: PpgAge uses data that consumer wearables already collect passively. No additional hardware, no blood tests, no clinical visits. The aging signal is already in the data — it just needs the right algorithms to extract it.

CosinorAge (npj Digital Medicine, 2024)

CosinorAge takes a different approach, deriving biological age from circadian rhythm patterns captured by wearable accelerometers [4].

The study analyzed data from approximately 80,000 participants and found that circadian rhythm characteristics are powerful aging biomarkers:

• Each one-year increase in CosinorAge corresponded to 8–12% higher all-cause mortality risk [4]
• Greater circadian rhythm intensity reduced odds of accelerated aging by 26–46%
• Greater circadian regularity lowered odds by 9–13%
• Delayed acrophase (peak activity timing shifting later) increased odds by 22% [5]

Sex differences were notable: females showed stronger vulnerability to timing disruptions, while males exhibited unique instability patterns linked to accelerated aging [5].

Wearable-ome meets epigenome (bioRxiv, 2023)

A study directly bridging wearable data and epigenetic clocks found that wearable-derived physiological metrics correlate significantly with epigenetic age acceleration [6]:

• Resting heart rate, VO2max, and large artery stiffness index all correlated with epigenetic age
• Activity minutes correlated with cardiovascular biomarkers that feed into epigenetic age calculations
• Sedentary time correlated inversely with cardiovascular health markers

This work validates the biological plausibility of wearable aging clocks — they’re not just finding statistical associations, they’re capturing the same underlying physiological processes that epigenetic clocks measure through different means.

Movement-based aging (GeroSense / earlier research)

Separate research has demonstrated that accelerometry data alone — patterns of movement, gait characteristics, and activity dynamics — can predict biological age with accuracy comparable to blood-based clocks for population-level monitoring [7]. This approach requires only a smartphone or basic activity tracker, no optical sensors needed.

The biomarkers that matter for longevity

The research converges on several wearable-derived biomarkers that carry the strongest aging signals:

Heart rate variability (HRV)

HRV declines with age and is one of the most validated non-invasive biomarkers for autonomic nervous system health. Higher HRV is consistently associated with lower biological age, better cardiovascular fitness, and greater stress resilience. Longitudinal HRV trends — not individual readings — are the meaningful signal for aging assessment.

Resting heart rate

Lower resting heart rate indicates greater cardiovascular efficiency. Elevated resting heart rate is associated with increased mortality risk across populations. The trend over months matters more than any single measurement.

VO2max (estimated)

VO2max — the body’s maximum oxygen consumption capacity — is one of the strongest predictors of all-cause mortality. Consumer wearables estimate VO2max from heart rate and activity data. While less precise than lab testing, wearable VO2max estimates capture the directional signal that matters for aging assessment.

Sleep architecture and regularity

Sleep quality degrades with biological aging: less deep sleep, more fragmentation, shifted timing. The CosinorAge research specifically demonstrates that circadian regularity and sleep timing are independent aging biomarkers [4]. Sleep consistency may matter as much as sleep duration.

Circadian alignment

The timing and regularity of daily activity patterns — when you’re active, when you rest, how consistent those patterns are — encode biological age information. Disrupted circadian rhythms correlate with accelerated aging across multiple studies [4][5].

Activity patterns

Not just total activity volume, but the distribution of activity intensities, the pattern of sedentary breaks, and the consistency of movement habits. GeroSense’s research demonstrates that movement dynamics alone carry sufficient aging information for population-level biological age estimation [7].

The longevity app landscape

A growing ecosystem of apps and platforms is translating this research into consumer products:

Wearable-first platforms

My Bio Age tracks 14 scientifically-weighted metrics using Apple Health data — VO2max, HRV, recovery capacity, sleep quality, stress resilience, and circadian alignment — to estimate biological age with six months of data history [8]. Processing happens entirely on-device for privacy.

blēo offers a dedicated wearable ring ($269) or band ($149) that tracks biological age, HRV, VO2max, sleep cycles, and nutrition, delivering personalized longevity coaching [9].

GeroSense uses AI to extract biological age signals from longitudinal step and heart rate patterns, offering accuracy comparable to blood-based clocks for digital health trials [7].

Hybrid platforms (wearable + blood)

LONGEVITAL combines wearable lifestyle data from WHOOP, Garmin, Fitbit, and Apple Watch with uploaded blood test results for comprehensive longevity recommendations [10]. This hybrid approach captures both the continuous behavioral signal from wearables and the molecular signal from blood biomarkers.

WHOOP + ARPA-H — WHOOP joined a $34.5 million ARPA-H initiative led by Stanford to develop the first FDA-grade “Intrinsic Capacity” score [11]. The PROSPR IC score integrates continuous wearable data with health surveys, functional assessments, and blood biomarkers to predict major health outcomes up to 20 years in advance.

The common pattern

Across the landscape, the most compelling products share a structure:

1. Continuous passive collection — health data gathered without manual input
2. Longitudinal baseline — biological age computed from weeks or months of data, not single measurements
3. Trend-based feedback — showing whether biological age is improving, stable, or worsening over time
4. Actionable context — connecting biological age changes to specific behaviors the user can influence (sleep timing, activity consistency, recovery practices)

Building longevity features: what product teams need

For product teams entering the longevity space or adding biological age features to existing health apps, the data infrastructure requirements are specific:

Multi-biomarker computation

Biological age estimation requires combining multiple health signals — HRV, resting heart rate, sleep metrics, activity patterns, circadian alignment — into a composite measure. This means your data pipeline needs to produce all of these biomarkers reliably across devices, not just one or two.

Longitudinal data depth

Unlike readiness scores that update daily, biological age requires weeks to months of baseline data to produce meaningful estimates. Your system needs to retain and access historical user data efficiently and compute trends over extended time windows.

Cross-device consistency

Users in the longevity space often switch devices or use multiple devices (watch during the day, ring at night). Biological age trends must remain consistent across these transitions — a device switch shouldn’t produce a sudden biological age jump. This requires robust cross-device normalization.

Personal baseline sensitivity

The meaningful signal in biological age isn’t the absolute number — it’s the trajectory. A user whose biological age drops from 45 to 42 over six months is making meaningful progress regardless of their chronological age. The system needs to detect and communicate these changes with appropriate confidence.

Behavioral attribution

The most engaging longevity products don’t just report biological age — they help users understand which behaviors drive it. “Your biological age improved by 0.8 years this quarter — the biggest contributors were improved sleep consistency and increased high-intensity activity.” This requires computing the relative contribution of different biomarkers to the overall estimate.

Health data APIs that deliver pre-computed biomarkers (HRV, sleep quality, activity intensity, circadian metrics), behavioral archetypes (sleep chronotype, activity consistency), and trend analysis provide the building blocks longevity products need — letting product teams focus on the aging model and user experience rather than the data collection and normalization pipeline.

Where this is heading

The convergence of longevity science and consumer wearable data points toward several developments:

Wearable aging clocks will become standard features. As the research matures (PpgAge, CosinorAge, and successors), expect major wearable platforms to incorporate biological age estimates alongside existing health metrics. Apple, Google, and Samsung all have the data and the research relationships to do this.

Hybrid models will deliver the highest accuracy. The future isn’t wearable-only or blood-only — it’s the combination. Continuous wearable data provides the behavioral and physiological signal. Periodic blood biomarkers provide the molecular signal. Together they produce biological age estimates with both high accuracy and high temporal resolution.

Insurance and employer wellness programs will adopt biological age metrics. Insurers already use wearable data for wellness incentives (see How Health Insurers Are Using Wearable Data to Cut Claims and Reward Prevention). Biological age is a more holistic metric than step counts — expect it to become a core metric in next-generation incentive programs.

Longevity will move from niche to mainstream. The biohacking market is growing at 19–25% annually [1][2]. As biological age tracking becomes available on devices people already own — no blood tests, no biohacking protocols — the audience expands from quantified-self enthusiasts to anyone curious about how well they’re aging.

The data infrastructure to build these products exists today. The research is published. The market is growing. The product teams that move first will define the category.